LipoMedics, Inc. develops personalized paclitaxel therapy based on its therapeutic drug monitoring device and platform for delivery of water insoluble drugs. Its platform technology is the phospholipid paclitaxel nanoparticle that upon injection disperses paclitaxel in the plasma compartment.